Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › TERT and BRAF mutations in human cancer

TERT and BRAF mutations in human cancer

US Patent 11319592 · Granted May 3, 2022

Estimated economic value: $49,173,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Regulation of mutant TERT by BRAF V600E/map kinase pathway through FOS/GABP in h2024
Activities of multiple cancer-related pathways are associated with BRAF mutation2023
RASAL1 is a major tumor suppressor gene in thyroid cancer2021
TERT promoter mutations in cancer2020
RASAL1 is a major tumor suppressor gene in thyroid cancer2018
Induction of thyroid iodide-handling gene expression in human cancers2018
Genetic amplification of IQGAP1 in cancer2017
Induction of thyroid iodide-handling gene expression in human cancers2016
Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene2015
Genetic make-up modifies cancer outcome2015
Induction of thyroid iodide-handling gene expression in human cancers2014